徐國辰，男，博士，心血管專業，副主任醫師。 1983~1989第四軍醫大學醫療系本科，獲學士學位；1991~1994第四軍醫大學研究生院心血管病學專業，獲碩士學位；2003~2005第四軍醫大學藥學系藥理學專業/北京大學人民醫院心血管病研究所，獲博士學位。 師從張寧仔、杜日映教授攻讀碩士學位期間，從事全軍“八五”攻關課題“血管支架預防/治療PTA/PTCA術后急性閉塞與慢性再狹窄”研究，研制成功首例國產不銹鋼動脈血管支架。 師從梅其柄、胡大一教授攻讀博士學位期間，從事“藥物基因組學與脂代謝紊亂患者的個體化治療”研究，開始涉足藥物相互作用和藥物個體化治療與遺傳基因多態性的相關研究領域。 自2000年從事心血管專科門診工作以來，開展心血管疾病的循證醫學研究，發表相關研究論文20余篇，參編心血管病學專著2部。2000年獲國家衛生部、中國中醫藥管理局、解放軍總后勤部聯合舉辦的“中國中醫藥科技大會”優秀論文獎；2004年赴新加坡參加“亞洲青年心血管病專家論壇”國際會議，就在中國本土開展的“藥物基因組學與脂代謝紊亂患者的個體化治療研究”發表演講。 Dr. Xu Guochen, associate chief physician, specializes in cardiovascular diseases. Dr. Xu graduated from the department of medicine (six-year course) of the Fourth Military Medical University in 1989, and was awarded Medical Bachelor Degree. He majored cardiovascular diseases at graduate school of the Fourth Military Medical University from 1991 to 1994, and was awarded Master Degree of Medical Science. He majored in cardiovascular pharmacology at the department of pharmacology of the Fourth Military Medical University and Angiocardiopathy Institute of Peking University People's Hospital from 2002 to 2005, and was awarded Doctoral Degree of Medical Science. Dr. Xu studied for master degree under supervision of professors Zhang Ningzi and Du Riying, and his research was focused on Preventing/Curing PTA/PTCA Postoperative Acute Closure and Chronic Restenosis by using Stent for Key Technologies Research and Development Program of the army during the 8th Five-Year Plan Period. He successfully developed the first domestic stainless steel coronary stent in China. Dr. Xu’s doctoral study on pharmacogenomics of individualized treatment of lipid metabolism disorder was conducted under supervision of professors Mei Qibing and Hu Dayi. Meanwhile Dr. Xu initiated the investigation on drug interactions, clinical individualized treatment genetic polymorphism. Dr. Xu has been working on evidence-based cardiovascular medicine since 2000. He has published more than 20 research articles, and participated in compil

高血壓 冠心病 心律失常等心血管病的診斷與藥物治療；冠狀動脈造影 血管內支架植入 射頻消融術等介入診療的前瞻指導與術后維護。在臨床實踐中從哲學層面把握藥物、心理、行為指導的個體化治療；在基礎研究方面主要從事基因多態性 藥物基因組學與循證心血管病學領域的研究